Fora Capital, LLC Collegium Pharmaceutical, Inc Transaction History

Fora Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$21.74 - $25.28 $29,044 - $33,774	-1,336 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$19.25 - $26.1 $69,454 - $94,168	-3,608 Reduced 72.98%	1,336 $32 Million
Q4 2020 Feb 12, 2021	BUY	$17.83 - $22.29 $88,151 - $110,201	4,944 New	4,944 $99,000
Q2 2020 Aug 14, 2020	SELL	$15.49 - $23.51 $27,974 - $42,459	-1,806 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$13.89 - $25.45 $38,391 - $70,343	-2,764 Reduced 60.48%	1,806 $29,000
Q4 2019 Feb 14, 2020	BUY	$10.7 - $22.24 $48,899 - $101,636	4,570 New	4,570 $94,000

247

37.6M

100K

10K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.06B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.